type-2-diabetes-mellitus

Documents about type-2-diabetes-mellitus

• The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial#18541ClinicalTrials.gov
• A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes#18542ClinicalTrials.gov
• Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin#18569ClinicalTrials.gov
• Impact Evaluation of a Mobile Health App to Improve Self-control and Health Outcomes of Patients With Type 2 Diabetes Mellitus (T2DM): Pilot Study "NOVAME"#18776ClinicalTrials.gov
• A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator#18778ClinicalTrials.gov
• Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease#18805ClinicalTrials.gov
• Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)#18825ClinicalTrials.gov
• Vascular Effects of Sitagliptin in Diabetes Mellitus#28523ClinicalTrials.gov
• Simplified Insulin Regimen for the Elderly#28543ClinicalTrials.gov
• Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus#28551ClinicalTrials.gov
• The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes#28568ClinicalTrials.gov
• iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)#28569ClinicalTrials.gov
• A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes#28571ClinicalTrials.gov
• Sitagliptin Added-on to Insulin Study (0431-051)#28584ClinicalTrials.gov
• Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus-2#28585ClinicalTrials.gov
• Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes#28589ClinicalTrials.gov
• Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes#67762ClinicalTrials.gov
• Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment#67774ClinicalTrials.gov
• The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)#67785ClinicalTrials.gov
• A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects#67786ClinicalTrials.gov
• Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin#67793ClinicalTrials.gov
• Observational Study of ASCVD Risks of Type 2 Diabetes in East China#67807ClinicalTrials.gov
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes#67811ClinicalTrials.gov
• A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)#67823ClinicalTrials.gov
• Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive#67829ClinicalTrials.gov
• Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM#67838ClinicalTrials.gov
• Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)#67841ClinicalTrials.gov
• The LoBAG Diet and Type 2 Diabetes Mellitus#67842ClinicalTrials.gov
• Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM#121279ClinicalTrials.gov
• Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes#121283ClinicalTrials.gov
• VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus#121293ClinicalTrials.gov
• Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)#121294ClinicalTrials.gov
• Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus#121295ClinicalTrials.gov
• Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie#121300ClinicalTrials.gov
• Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)#121307ClinicalTrials.gov
• Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)#123420ClinicalTrials.gov
• Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes#123425ClinicalTrials.gov
• An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice#329412ClinicalTrials.gov
• Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects#329438ClinicalTrials.gov
• How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.#329440ClinicalTrials.gov
• Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease#329449ClinicalTrials.gov
• Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes#329462ClinicalTrials.gov
• Effectiveness of PRECEDE Model for Health Education on Changes and Level of Control in Patients With Type 2 Diabetes Mellitus#329467ClinicalTrials.gov
• Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone#329492ClinicalTrials.gov
• Dapagliflozin vs Empagliflozin on Flow Mediated Dilation in Type 2 Diabetes Mellitus#329497ClinicalTrials.gov
• Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes#332667ClinicalTrials.gov
• STUDIIO-Diabetes Pilot: STUdy of Drug Insurance to Improve Outcomes of Diabetes#332672ClinicalTrials.gov
• A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus#332696ClinicalTrials.gov
• A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes#332700ClinicalTrials.gov
• A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM#332718ClinicalTrials.gov

Related topics